BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector ... disease, chronic kidney disease (CKD), and chronic obstructive pulmonary disease (COPD).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback